Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The development and validation of a global advanced development framework for the pharmacy workforce: a four-stage multi-methods approach.

International journal of clinical pharmacy·2023
Same author

Strengthening Primary Healthcare through accelerated advancement of the global pharmacy workforce: a cross-sectional survey of 88 countries.

BMJ open·2022
Same author

Development of a Vertically Integrated Pharmacy Degree.

Pharmacy (Basel, Switzerland)·2021
Same author

Developing a Global Community of Practice for Pharmacy Workforce Resilience-Meet GRiT.

Pharmacy (Basel, Switzerland)·2021
Same author

Trends in advanced practice and specialisation in the global pharmacy workforce: a synthesis of country case studies.

The International journal of pharmacy practice·2020
Same author

A global survey on trends in advanced practice and specialisation in the pharmacy workforce.

The International journal of pharmacy practice·2020
Same journal

Tailoring the CFIR to Medication Adherence Interventions: A Delphi and Living Lab Study.

Pharmacy (Basel, Switzerland)·2026
Same journal

Seasonal Influenza Vaccination Uptake, Illness and Economic Burden, and Vaccine Information Exposure Among Young Adults in the San Francisco Bay Area.

Pharmacy (Basel, Switzerland)·2026
Same journal

Impact of an Interdisciplinary Educational Intervention on Healthcare Provider Knowledge and Beliefs Regarding Opioid Harm Reduction in Older Adults: A Pre-Post Survey Study.

Pharmacy (Basel, Switzerland)·2026
Same journal

From Laboratory to Patient Access: A Scoping Review of the Multi-Dimensional Challenges in Drug Repurposing.

Pharmacy (Basel, Switzerland)·2026
Same journal

Kisspeptin as a Precision Biomarker in Personalized Pharmacy: Implications for Individualized Monitoring of Early Pregnancy Viability.

Pharmacy (Basel, Switzerland)·2026
Same journal

Enhancing Discretion and Consistency in Emergency Contraception Counselling: Implementation of a Digital Support Tool in Community Pharmacies.

Pharmacy (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Entrustable Professional Activities for Pharmacists Carrying Out Medication Management Reviews.

Carmen Abeyaratne1, Nadine Fawal1, Kirsten Galbraith1

  • 1Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC 3052, Australia.

Pharmacy (Basel, Switzerland)
|May 27, 2026
PubMed
Summary
This summary is machine-generated.

Twelve of fourteen Entrustable Professional Activities (EPAs) were suitable for pharmacists performing medication management reviews (MMRs). Five EPAs aligned perfectly with six national performance outcomes, enhancing pharmacist credentialing.

Keywords:
EPAsEntrustable Professional Activitiesmedication management reviewspharmacy

More Related Videos

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: May 28, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

  • Pharmacy Practice
  • Pharmacist Education
  • Healthcare Professional Competency

Background:

  • Entrustable Professional Activities (EPAs) are crucial for defining and assessing professional competence.
  • Medication Management Reviews (MMRs) are a key service provided by pharmacists, requiring specific skills and outcomes.
  • Existing EPAs need validation and alignment with national performance outcomes (POs) for effective credentialing.

Purpose of the Study:

  • To evaluate the suitability of pre-validated EPAs for pharmacists conducting MMRs.
  • To align these EPAs with nationally accepted POs for MMR pharmacists in Australia.
  • To establish a framework for credentialing MMR pharmacists using validated EPAs and POs.

Main Methods:

  • A two-phase study involving Subject-Matter Experts (SMEs) was conducted.
  • Phase 1: SMEs rated the relevance of 14 EPAs for MMR pharmacists using a Likert scale (70% threshold for progression).
  • Phase 2: Qualified EPAs were mapped against 24 national POs for MMR pharmacists.

Main Results:

  • Twelve out of 14 EPAs met the 70% threshold and proceeded to Phase 2.
  • Seven of eight recruited SMEs completed both study phases.
  • Five EPAs demonstrated 100% alignment with six specific POs for MMR pharmacists.

Conclusions:

  • A significant number of previously validated EPAs are suitable for pharmacists undertaking MMRs.
  • The mapping exercise successfully aligned EPAs with national POs, supporting credentialing.
  • This study provides a foundation for standardized assessment and credentialing of MMR pharmacists in Australia.